Playback speed
×
Share post
Share post at current time
0:00
/
0:00
Transcript

The Case for Keto for Type 1 Diabetes with Andrew Koutnik, Ph.D.

New data support the safety and efficacy of the ketogenic diet as a metabolic therapy.

Greetings!

Today’s interview is with Andrew Koutnik, Ph.D.

Andrew is a research scientist at Sansum Diabetes Research Institute, where he’s investigating metabolic therapies for health and disease. His mission is to optimize metabolic health and patient outcomes for people living with type 1 diabetes.

Andrew is unique because he himself has type 1 diabetes. This allows him to add a bit of personal touch and a lot of passion into the work he’s doing.

Andrew joins me to talk about a case study (two papers) that he and colleagues just published on the long-term safety and efficacy of the ketogenic diet for an individual with type 1 diabetes who had been using the ketogenic diet for more than 10 years (spoiler alert: it’s Andrew).

We talk about why the ketogenic diet is helpful for people with diabetes and then dive into the details of each study to explore how 10 years on the diet affected cardiovascular health risk factors and clinical biomarkers.

Andrew posted two great threads about the papers on X. You can check those out below. Make sure to give Andrew a follow as well while you’re there.

Part I: 10-Years longitudinal data on KETOGENIC DIET and Safety, Efficacy & Advanced Cardiovascular Physiology in a patient with HIGH RISK cardiovascular disease (Type 1 Diabetes)?

Part II: 10-Year Longitudinal Data On Ketogenic Diet Adverse Events, Bone Mineral Density, Thyroid Function, and Kidney Function

Here are the links to each paper:

Advanced Cardiovascular Physiology in an Individual with Type 1 Diabetes After 10-Year Ketogenic Diet

Efficacy and Safety of Long-term Ketogenic Diet Therapy in a Patient With Type 1 Diabetes